P J BURKE - JoVE Visualize

Showing results (91-100 of 119) with videos related to

Pageof 12

Sort By:

Ophthalmology|June 1, 1989

Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosisD R Guyer, A P Schachat, S Vitale, et al.

Journal of Medicinal Chemistry|December 22, 1995

Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT)C J Springer, R Dowell, P J Burke, et al.

British Journal of Cancer|December 1, 1990

Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in miceP Antoniw, C J Springer, K D Bagshawe, et al.

Annals of Internal Medicine|January 1, 1987

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trialJ E Karp, W G Merz, C Hendricksen, et al.

Blood|August 1, 1987

Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignanciesS B Baylin, E R Fearon, B Vogelstein, et al.

Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1986

Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tractJ E Karp, W G Merz, C Hendricksen, et al.

Leukemia & Lymphoma|July 31, 1998

Topoisomerase II and the response to antileukemic therapyS H Kaufmann, S D Gore, C B Miller, et al.

Cancer|February 1, 1994

Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapyS K Sharma, K D Bagshawe, P J Burke, et al.

Blood|January 15, 1994

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemiaS H Kaufmann, J E Karp, R J Jones, et al.

Blood|November 23, 2000

Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemiaP A Svingen, J E Karp, S Krajewski, et al.

Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:

Pageof 12

Ophthalmology|June 1, 1989

Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosisD R Guyer, A P Schachat, S Vitale, et al.

Journal of Medicinal Chemistry|December 22, 1995

Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT)C J Springer, R Dowell, P J Burke, et al.

British Journal of Cancer|December 1, 1990

Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in miceP Antoniw, C J Springer, K D Bagshawe, et al.

Annals of Internal Medicine|January 1, 1987

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trialJ E Karp, W G Merz, C Hendricksen, et al.

Blood|August 1, 1987

Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignanciesS B Baylin, E R Fearon, B Vogelstein, et al.

Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1986

Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tractJ E Karp, W G Merz, C Hendricksen, et al.

Leukemia & Lymphoma|July 31, 1998

Topoisomerase II and the response to antileukemic therapyS H Kaufmann, S D Gore, C B Miller, et al.

Cancer|February 1, 1994

Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapyS K Sharma, K D Bagshawe, P J Burke, et al.

Blood|January 15, 1994

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemiaS H Kaufmann, J E Karp, R J Jones, et al.

Blood|November 23, 2000

Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemiaP A Svingen, J E Karp, S Krajewski, et al.

Pageof 12